PARP1 and cancer: Since our biopsies have part cancer and part non-malignant tissue, we quantified PARP1 mRNA using RNA-fluorescence in situ hybridisation (RNA-FISH) while maintaining spatial resolution in order to be able to correlate PARP mRNA to the pathologically verified cancer areas.